Add Formweb to your mobile device
Following is a P and T Committee update (from the April 26th meeting). Starting date for specific programs is 2 May 2016, unless otherwise noted. Please let me know if you have any questions or comments. Don’t forget to check the “New Drug Monitoring Spotlight” section of the website, which provides important monitoring information about newly approved drugs. Also, attached is the updated version of the “Not Stocked, Not Ordered” drug list with the new additions highlighted in red.
Below is the memo with links to the drug monographs, protocols, and formulary documents. Click to access the full P&T packet for this month, or here to access the P&T packet archive.
|
Drug or Drug Class |
Formulary Decision |
Comments |
| cariprazine (Vraylar) | Formulary, restricted to hospital initiation by psychiatrists. | Not restricted by prescriber if it is a home medication being continued. |
| ixazomib (Ninlaro) | Non-formulary, not stocked. | Defer initiation to after hospital discharge. May use home supply |
| sonidegib (Odomzo) | Non-formulary, not stocked. | Defer initiation to after hospital discharge. May use home supply. |
| castor oil-balsam peru (Proderm) Topical Spray | Formulary. | Replaces Granulex spray, for use in wound care |
| Influenza Vaccine Quadravalent | Formulary - workhorse flu vaccine for the 2016-2017 season. | Trivalent vaccine product not readily available in a unit dose form; Flublok restricted to people with severe egg allergy. |
| meloxicam in microparticle form (Vivlodex) |
Non-formulary, not stocked. Automatic interchange approved. |
Interchange to generic regular meloxicam product. |
| levodopa-carbidopa (Duopa) enteral suspension | Non-formulary, not stocked. | Not available as hospital stock, inpatient must use own home supply. |
| budesonide (Pulmicort Respules) | Formulary, for use in both adults and pediatrics. | Adult dosing is off label but supported by studies for asthma and COPD. |
|
sodium biphosphate-sodium phosphate (Fleets Phosphasoda Enema)
built as Fleet Enema Extra, Fleets Enema Extra |
Re-classifed as formulary, restricted to no substitution with frequency and renal function restrictions. |
Orders for Phosphosoda enemas should be specified as NO SUB in patients with adequate renal function. Patients with CrCl < 30 mL/min or on renal replacement therapy should not receive the phosphosoda enema. Patients may only receive 1 NO SUB order per 24 hour period, not to exceed 2 doses within 14 days. |
| Route Conversion for Oral to NG/OG/G Tube | Policy Updated. | Prescriber must be contacted if only enteral route available is an ND tube or J tube. |